Anzeige
Mehr »
Login
Dienstag, 23.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Breaking News: InnoCan startet in eine neue Ära – FDA Zulassung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
109 Leser
Artikel bewerten:
(0)

Global Brain Monitoring Devices Market 2017-2021 - Key Vendors are Compumedics, GE Healthcare, Medtronic, Natus Medical & NIHON KOHDEN

DUBLIN, July 06, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Brain Monitoring Devices Market 2017-2021" report to their offering.

Research and Markets Logo

The global brain monitoring devices market to grow at a CAGR of 8.72% during the period 2017-2021.

Global Brain Monitoring Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market. To calculate the market size, the report considers revenue generated by the sales of different brain monitoring devices.

According to the report, one driver in the market is increasing number of neurological patients. Various autoimmune and cardiovascular diseases, neurological and sleep disorders, and brain tumors affect the functioning of the brain. The brain monitoring devices are required for the diagnosis and monitoring of these diseases. Over the past decade, the world has witnessed a rapid increase in the number of individuals with brain disorders, which is boosting the demand for brain monitoring devices globally.

One trend in the market is application of health informatics and monitoring solutions. Health informatics is an intersection of information technology and healthcare dynamics. It deals with the acquisition, transmission, processing, storage, retrieval, and use of health information.

Further, the report states that one challenge in the market is under-penetration of market. Emerging economies have a high burden of neurological disease and TBIs. Due to the high prevalence of these disorders, the brain monitoring devices have gained a significant growth in Africa, Latin America, Middle East, and APAC. The market for low-cost products is in high demand in these regions. Developing strategic partnerships and collaborations among the healthcare facilities can fuel the growth of this market in emerging economies.

Key vendors

  • Compumedics
  • GE Healthcare
  • Medtronic
  • Natus Medical
  • NIHON KOHDEN

Other prominent vendors

  • Advanced Brain Monitoring
  • CAS Medical Systems
  • Clinical Science System
  • Elekta
  • EMS Biomedical
  • Integra LifeSciences
  • Masimo
  • Nonin Medical
  • Ornim
  • Tristan Technologies

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market landscape

Part 06: Pipeline analysis

Part 07: Market segmentation based on drug class

Part 08: Drug profile of key OAB therapeutics

Part 09: Geographical segmentation

Part 10: Decision framework

Part 11: Drivers and challenges

Part 12: Market trends

Part 13: Vendor landscape

Part 14: Key vendor analysis

Part 15: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/2ck8br/global_brain

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.